Table 3 Associations between baseline CD28⁻CD57⁺CD8⁺ T-cell proportion and clinical characteristics.

From: Prognostic value of CD28⁻CD57⁺CD8⁺ T cells for early immunotherapy response in hepatocellular carcinoma: a prospective observational study

Clinical Variable

r/U

P value

Age

0.187

0.306

Maximum Tumor Diameter

0.430

0.014

AFP Level

−0.089

0.626

Number of Tumors (< 3 vs. ≥3)

92

0.875

BCLC Stage (B vs. C)

107.5

0.494

Back to article page